Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction
Status:
Terminated
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 observational nonrandomized pilot investigation to evaluate the safety and
efficacy of Sodium Nitrite administration for the reduction of Primary Graft Dysfunction
(PGD) in patients undergoing lung transplant. The study will enroll 8 subjects, undergoing
lung transplant at the University of Pittsburgh Medical Center (UPMC).